The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Redmile Biopharma Investments Iii, L.p. since 2021.
This trader's CIK number is 1838746.
At the time of last reporting, Redmile Biopharma Investments Iii, L.p. was the Officer of Attovia Therapeutics, Inc.. (stock ticker symbol ATTO).
Also see all insider trading activities at Attovia Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | TRDA | 1,000,000 | $20,000,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | ATTO | 600,000 | $10,200,000 | 0 | $0 | 0 | $0 |
1. Entrada Therapeutics, Inc. (TRDA)
2. Attovia Therapeutics, Inc. (ATTO)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-11-02 | TRDA | Buy | 1,000,000 | 20.00 | 20,000,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-08-06 | ATTO | Buy | 600,000 | 17.00 | 10,200,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Redmile Biopharma Investments Iii, L.p. (Officer of Attovia Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.